Average Insider

Where insiders trade, we follow

$FBRX
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Healthcare
Sector
Biotechnology
Industry
Paul A. Wagner
CEO
14
Employees
$76.99
Current Price
$370.85M
Market Cap
52W Low$10.11
Current$76.9999.7% above low, 0.3% below high
52W High$77.20

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00---
Sells00--
2 monthsBuys00---
Sells00--
3 monthsBuys00---
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
No transactions in the last 3 months. Sign up free to see 12 months of history.

Upcoming Earnings

Scheduled earnings reports
Nov 13, 2026
EPS
Estimated-$0.90
ActualN/A
Revenue
EstimatedN/A
ActualN/A

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Version: v26.10.12